Moss Genomics Inc. is a biotechnology company specializing in genomics and microbiome research to deliver advanced genetic insights and personalized health solutions. Headquartered in Vancouver, Canada, and founded in 2018, it was formerly known as Nou Camp Capital Corp. before rebranding in July 2021. The company operates as an online consumer genomics firm, utilizing DNA and gut microbiome sequencing data combined with artificial intelligence to analyze gut biology and recommend improvements for individual health. Its offerings include a gut microbiome sequencing panel, detailed health insights reports, and custom prebiotic and probiotic formulations focused on personalized health, anti-aging, and wellness products. Moss Genomics also incorporates blockchain technology to secure genomic data and enhance user control, while employing an Ethereum accumulation strategy in its treasury management, holding Ethereum on its balance sheet. This positions it at the intersection of biotechnology, AI, and blockchain within the health technology sector.